This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Stealth BioTherapeutics Dirección
Dirección controles de criterios 1/4
Información clave
Reenie McCarthy
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | 4.1yrs |
Participación del CEO | 0.2% |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | 4.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Stealth Biotherapeutics chief financial officer Robert Weiskopf leaves company
Sep 30Stealth BioTherapeutics shares pop ~20% premarket after co agrees to go private
Aug 01Stealth BioTherapeutics: A Net-Net Biopharma Going Private
Jul 26Stealth BioTherapeutics receives Nasdaq non-compliance receipt
Jul 11Stealth Biotherapeutics shares soar on EMA orphan drug status for elamipretide
Jun 01Stealth BioTherapeutics skyrockets on data for elamipretide studies
May 06FDA accepts Stealth Bio's Pre-NDA meeting request for elamipretide
Jan 06Reflecting on Stealth BioTherapeutics' (NASDAQ:MITO) Share Price Returns Over The Last Year
Dec 31Stealth Bio launches $3.2M registered direct offering
Nov 20CEO
Reenie McCarthy (57 yo)
4.1yrs
Permanencia
Ms. Irene P. McCarthy, also known as Reenie, J.D., has been President, Chief Executive Officer and Secretory of Stealth BioTherapeutics Corp (formerly known as Stealth BioTherapeutics Inc.) since October 2...
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 4.4yrs | sin datos | 0.19% $ 45.9k | |
Independent Non-Employee Director | 4.4yrs | sin datos | 0% $ 0 | |
Independent Non-Employee Director | 4.4yrs | sin datos | 0% $ 0 | |
Independent Director | 3.3yrs | sin datos | 0% $ 0 | |
Chairman of the Board | 4.4yrs | sin datos | 0% $ 0 | |
Director | 1.9yrs | sin datos | 0% $ 0 | |
Non-Employee Director | 5.3yrs | sin datos | 0.11% $ 25.9k |
4.4yrs
Permanencia media
72yo
Promedio de edad
Junta con experiencia: MITO's board of directors are considered experienced (4.4 years average tenure).